Trends in the use of typical and atypical antipsychotics in children and adolescents

Nick C. Patel, M. Lynn Crismon, Kimberly Hoagwood, Michael T. Johnsrud, Karen L. Rascati, James P. Wilson, Peter S. Jensen

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

Objective: To estimate prevalence rates of antipsychotic use in children and adolescents from 1996 to 2001 in three state Medicaid programs (midwestern [MM], southern [SM], and western [WM]) and one private managed care organization (MCO). Method: Prescription claims were used to evaluate antipsychotic prevalence, defined as the number of children and adolescents up to the age of 19 years with at least one prescription claim for an antipsychotic per 1,000 enrolled youths. Results: From 1996 to 2001, the prevalence of total antipsychotic use increased in each program (MM: 4.7 to 14.3 per 1,000; SM: 6.3 to 15.5; WM: 4.5 to 6.9; and MCO: 1.5 to 3.4). Typical antipsychotic use decreased (MM: 3.7 to 2.0 per 1,000; SM: 4.6 to 1.5; WM: 4.4 to 1.3; and MCO: 1.2 to 0.9), while atypical antipsychotic use dramatically increased (MM: 1.4 to 13.1 per 1,000; SM: 2.5 to 14.9; WM: 0.3 to 6.2; and MCO: 0.4 to 2.7). Conclusions: The increased prevalence of antipsychotic use in children and adolescents from 1996 to 2001 was attributed to increased use of atypical antipsychotics. Given the limited data with atypical antipsychotics in youths, this emphasizes the need for additional studies of these agents and other treatment modalities in this population.

Original languageEnglish (US)
Pages (from-to)548-556
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume44
Issue number6
DOIs
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Antipsychotic Agents
Medicaid
Managed Care Programs
Organizations
Prescriptions
Population
SM 1

Keywords

  • Antipsychotics
  • Pharmacoepidemiology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., & Jensen, P. S. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 548-556. https://doi.org/10.1097/01.chi.0000157543.74509.c8

Trends in the use of typical and atypical antipsychotics in children and adolescents. / Patel, Nick C.; Crismon, M. Lynn; Hoagwood, Kimberly; Johnsrud, Michael T.; Rascati, Karen L.; Wilson, James P.; Jensen, Peter S.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 44, No. 6, 06.2005, p. 548-556.

Research output: Contribution to journalArticle

Patel, Nick C. ; Crismon, M. Lynn ; Hoagwood, Kimberly ; Johnsrud, Michael T. ; Rascati, Karen L. ; Wilson, James P. ; Jensen, Peter S. / Trends in the use of typical and atypical antipsychotics in children and adolescents. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2005 ; Vol. 44, No. 6. pp. 548-556.
@article{82fd6b1448f2482e963db91faeb4ed51,
title = "Trends in the use of typical and atypical antipsychotics in children and adolescents",
abstract = "Objective: To estimate prevalence rates of antipsychotic use in children and adolescents from 1996 to 2001 in three state Medicaid programs (midwestern [MM], southern [SM], and western [WM]) and one private managed care organization (MCO). Method: Prescription claims were used to evaluate antipsychotic prevalence, defined as the number of children and adolescents up to the age of 19 years with at least one prescription claim for an antipsychotic per 1,000 enrolled youths. Results: From 1996 to 2001, the prevalence of total antipsychotic use increased in each program (MM: 4.7 to 14.3 per 1,000; SM: 6.3 to 15.5; WM: 4.5 to 6.9; and MCO: 1.5 to 3.4). Typical antipsychotic use decreased (MM: 3.7 to 2.0 per 1,000; SM: 4.6 to 1.5; WM: 4.4 to 1.3; and MCO: 1.2 to 0.9), while atypical antipsychotic use dramatically increased (MM: 1.4 to 13.1 per 1,000; SM: 2.5 to 14.9; WM: 0.3 to 6.2; and MCO: 0.4 to 2.7). Conclusions: The increased prevalence of antipsychotic use in children and adolescents from 1996 to 2001 was attributed to increased use of atypical antipsychotics. Given the limited data with atypical antipsychotics in youths, this emphasizes the need for additional studies of these agents and other treatment modalities in this population.",
keywords = "Antipsychotics, Pharmacoepidemiology",
author = "Patel, {Nick C.} and Crismon, {M. Lynn} and Kimberly Hoagwood and Johnsrud, {Michael T.} and Rascati, {Karen L.} and Wilson, {James P.} and Jensen, {Peter S.}",
year = "2005",
month = "6",
doi = "10.1097/01.chi.0000157543.74509.c8",
language = "English (US)",
volume = "44",
pages = "548--556",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Trends in the use of typical and atypical antipsychotics in children and adolescents

AU - Patel, Nick C.

AU - Crismon, M. Lynn

AU - Hoagwood, Kimberly

AU - Johnsrud, Michael T.

AU - Rascati, Karen L.

AU - Wilson, James P.

AU - Jensen, Peter S.

PY - 2005/6

Y1 - 2005/6

N2 - Objective: To estimate prevalence rates of antipsychotic use in children and adolescents from 1996 to 2001 in three state Medicaid programs (midwestern [MM], southern [SM], and western [WM]) and one private managed care organization (MCO). Method: Prescription claims were used to evaluate antipsychotic prevalence, defined as the number of children and adolescents up to the age of 19 years with at least one prescription claim for an antipsychotic per 1,000 enrolled youths. Results: From 1996 to 2001, the prevalence of total antipsychotic use increased in each program (MM: 4.7 to 14.3 per 1,000; SM: 6.3 to 15.5; WM: 4.5 to 6.9; and MCO: 1.5 to 3.4). Typical antipsychotic use decreased (MM: 3.7 to 2.0 per 1,000; SM: 4.6 to 1.5; WM: 4.4 to 1.3; and MCO: 1.2 to 0.9), while atypical antipsychotic use dramatically increased (MM: 1.4 to 13.1 per 1,000; SM: 2.5 to 14.9; WM: 0.3 to 6.2; and MCO: 0.4 to 2.7). Conclusions: The increased prevalence of antipsychotic use in children and adolescents from 1996 to 2001 was attributed to increased use of atypical antipsychotics. Given the limited data with atypical antipsychotics in youths, this emphasizes the need for additional studies of these agents and other treatment modalities in this population.

AB - Objective: To estimate prevalence rates of antipsychotic use in children and adolescents from 1996 to 2001 in three state Medicaid programs (midwestern [MM], southern [SM], and western [WM]) and one private managed care organization (MCO). Method: Prescription claims were used to evaluate antipsychotic prevalence, defined as the number of children and adolescents up to the age of 19 years with at least one prescription claim for an antipsychotic per 1,000 enrolled youths. Results: From 1996 to 2001, the prevalence of total antipsychotic use increased in each program (MM: 4.7 to 14.3 per 1,000; SM: 6.3 to 15.5; WM: 4.5 to 6.9; and MCO: 1.5 to 3.4). Typical antipsychotic use decreased (MM: 3.7 to 2.0 per 1,000; SM: 4.6 to 1.5; WM: 4.4 to 1.3; and MCO: 1.2 to 0.9), while atypical antipsychotic use dramatically increased (MM: 1.4 to 13.1 per 1,000; SM: 2.5 to 14.9; WM: 0.3 to 6.2; and MCO: 0.4 to 2.7). Conclusions: The increased prevalence of antipsychotic use in children and adolescents from 1996 to 2001 was attributed to increased use of atypical antipsychotics. Given the limited data with atypical antipsychotics in youths, this emphasizes the need for additional studies of these agents and other treatment modalities in this population.

KW - Antipsychotics

KW - Pharmacoepidemiology

UR - http://www.scopus.com/inward/record.url?scp=19344378756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19344378756&partnerID=8YFLogxK

U2 - 10.1097/01.chi.0000157543.74509.c8

DO - 10.1097/01.chi.0000157543.74509.c8

M3 - Article

C2 - 15908837

AN - SCOPUS:19344378756

VL - 44

SP - 548

EP - 556

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 6

ER -